Lonza BioResearch Solutions

Lonza Bioresearch Solutions provides researchers with the tools needed to develop and test therapeutics, from basic research to final product release.

[Lonza BioResearch Solutions @LonzaBioRes]

Just released! Roundtable discussion „Accelerating time to market for CAR-T cell therapies through translatable workflow” by BioInsights, featuring Isabelle Riviére , Metin Kurtoglu, and Lonza’s Tariq Haq. Register:
https://t.co/7jAghnj4ZI
#celltherapy #cart #immunotherapy

[Lonza BioResearch Solutions @LonzaBioRes]

https://t.co/oE45zuZfkH

[Lonza BioResearch Solutions @LonzaBioRes]

Read our blog article highlighting some of the challenges and opportunities with Leukopaks.
#drugdiscovery #drugdevelopment #lifescience https://t.co/oLYcouDsI4

[Lonza BioResearch Solutions @LonzaBioRes]

Watch this video to learn how to successfully thaw and plate primary hepatocytes from the experts at Lonza. Glean tips and tricks to truly maximize your final cell count. https://t.co/WT3GYWGlim
#drugdiscovery #drugdevelopment #lifescience

[Lonza BioResearch Solutions @LonzaBioRes]

It’s not too late to register for our APAC Virtual Cell and Gene Therapy Event next week. Check out the agenda, list of speakers and register now for your free seat at the event: https://t.co/0PNUeGNXUP #celltherapy #genetherapy #cancerimmunotherapy

[Lonza BioResearch Solutions @LonzaBioRes]

Attending the NVGCT Symposium? Find out how our TheraPEAK® Media, Nucleofector® Transfection Technology or the Cocoon® Platform for patient-specific manufacturing can help you accelerate the development of cell and gene therapies.
https://t.co/2QLNJz2vBZ

[Lonza BioResearch Solutions @LonzaBioRes]

Join our Virtual #CellandGeneTherapy event from 9 – 10 November 2021 where we will bring together experts from the APAC region to discuss regulatory trends, key challenges and solutions for translational research to early clinic and GMP manufacturing: https://t.co/0PNUeGNXUP

[Lonza BioResearch Solutions @LonzaBioRes]

Watch recordings from our "De-risking Early Drug Discovery with Advanced Cell Culture Systems" virtual workshop featuring presentations from four renowned scientists and an engaging Roundtable: https://t.co/FTegevtGXX #drugdiscovery #drugdevelopment #lifesciences

[Lonza BioResearch Solutions @LonzaBioRes]

There's still time to register for the HRA 16th Annual Assembly: Are standard hepatocyte models/test systems still good enough? Our very own Maureen Bunger, PhD, MBA is speaking as aa expert panelist. Register for tomorrow's event here: https://t.co/GmHxxQa15P
#adme #toxicology

[Lonza BioResearch Solutions @LonzaBioRes]

Did You Know…Lonza CellBio Services has over 30 years of primary cell culture and isolation expertise with an extensive tissue network, and dedicated project management team to meet your needs. Contact us to discuss your next primary cell project: https://t.co/84WiK8ylod

[Lonza BioResearch Solutions @LonzaBioRes]

Are you joining the CHI Immunogenicity and Bioassay Summit next week? Then be sure to add our presentation to your personal agenda! Our expert, Noel Smith, will be sharing how high quality, reliable data can be attained to support your regulatory needs.
https://t.co/taVh5w7H1s

[Lonza BioResearch Solutions @LonzaBioRes]

Lonza’s new Tox-Talks are personalized informal meetings between your scientists and ours to discuss use of primary cells and advanced cell models to help you build better predictive models for your toxicity testing program. Sign up today: https://t.co/bBtp3oq65Z

[Lonza BioResearch Solutions @LonzaBioRes]

Innovative Therapies Days is on 14 - 15 Oct. in France. Meet our expert Valérie Boyer-Lancereaux at booth # 6 and learn how our solutions can help you accelerate the development of cell and gene therapies. https://t.co/DAa4SlQXcU

[Lonza BioResearch Solutions @LonzaBioRes]

Genome-editing with 4D-Nucleofector® System was recently used to generate new cellular models for #parkinsonsdisease. Read our latest blog post to learn more: https://t.co/YKK1FWF6HJ
#drugdiscovery #lifesciences #transfection

[Lonza BioResearch Solutions @LonzaBioRes]

Learn how you can use human bronchial epithelial (HBE) cells from normal, COPD-, and asthma-diagnosed human donor lung tissues in an air-liquid interface (ALI) model to assess potential phenotypic and gene expression changes in vitro: https://t.co/W2c9A5FKB8

[Lonza BioResearch Solutions @LonzaBioRes]

Last chance to register for our workshop "De-risking Early Drug Discovery with Advanced Cell Culture Systems". Visit our event page for more info and register: https://t.co/3t4CAm8v1x

[Lonza BioResearch Solutions @LonzaBioRes]

Watch the recordings of our recent Cell and Gene Therapy Workshop for application highlights, expert advice and hands-on tips, covering topics from regulatory guidelines to #genomeediting or solutions for closing and automating CAR-T processes. Register: https://t.co/RDTboT5GH0

[Lonza BioResearch Solutions @LonzaBioRes]

We're counting down to our workshop "De-risking Early Drug Discovery with Advanced Cell Culture Systems". Visit our event page for more info and register:
https://t.co/3t4CAm8v1x

[Lonza BioResearch Solutions @LonzaBioRes]

Dr. Audrey Dubourg, Product Manager, CN Bio Innovations will be speaking at our workshop "De-risking Early Drug Discovery with Advanced Cell Culture Systems" on 6 October. Register to see her presentation:
https://t.co/3t4CAm8v1x

[Lonza BioResearch Solutions @LonzaBioRes]

See how breakthrough Nucleofector® Technology innovations in transfection and electroporation culminate in the next generation 4D-Nucleofector® System: https://t.co/nBa1fqJH16